At Polpharma Biologics, we create value by identifying high‑impact opportunities and transforming them into successful biosimilar assets. The Portfolio & Market Intelligence Lead plays a pivotal role at the front end of this value‑creation model, shaping how product opportunities are identified, assessed, and prioritized. This role integrates market insight, portfolio strategy, and robust business‑case modelling to guide investment decisions and ensure programs are positioned for strong commercial performance. Aligned with our strategic driver Portfolio with Impact, the position is responsible for building and continuously refining a competitive biosimilars pipeline – ensuring each program is grounded in compelling market positioning, sound economics, and competitive Cost of Goods (COGS).
Scope of duties
Provide strategic insights into global biosimilar markets to inform portfolio shaping and investment decisions.
Develop and maintain comprehensive global market, patient, and competitive insights across key therapeutic areas.
Continuously monitor innovator pipelines, biosimilar development programs, regulatory trends, and pricing dynamics.
Build and strengthen internal knowledge of disease areas, stakeholder ecosystems, and competitive landscapes.
Translate market signals into clear, actionable insights that guide portfolio strategy and support leadership decision‑making.
Portfolio Strategy & Business Case Development
Shape the company’s biosimilars portfolio through disciplined opportunity assessment and rigorous economic modelling.
Identify and assess pipeline opportunities based on market attractiveness, competitive dynamics, development feasibility, and economic potential.
Develop and maintain robust business‑case models that integrate market assumptions, development costs, manufacturing economics, and competitive landscape insights.
Deliv